Bermuda-based consolidation vehicle is the third incarnation of Sir Clive Cowdery’s acquisitive Resolution
Resolution Life, an insurance consolidation vehicle founded by Sir Clive Cowdery, has completed a $3bn fundraising and added several of the investors who contributed, including JPMorgan and KKR, to its board.
Bermuda-based Resolution Life, founded in 2017, is Cowdery’s latest vehicle for buying and merging insurers.
A previous UK company, also called Resolution, acquired a series of businesses in the 2000s before merging with Britannic Group and then being sold to Hugh Osmond’s Pearl Group, later becoming Phoenix Group.
Cowdery relaunched the Resolution business a second time, buying Friends Life in 2009 and adding other businesses from Axa Sun Life and Bupa. This was then sold to Aviva in 2014.
This latest, third incarnation has acquired $5.7bn of life insurance policies from US insurer Symetra, and in October 2018, agreed to buy various insurance businesses from AMP in Australia and New Zealand for A$3bn.
In a statement on November 18, Resolution Life said it has raised $3bn from investors to finance further deals.
Representatives from JPMorgan, KKR, the Nippon Life Insurance Company, Singaporean sovereign wealth fund Temasek, and USS, the UK’s largest pension fund, will join its board — alongside an unnamed Middle Eastern sovereign fund.
Credit Suisse Asset Management acted as a placement agent on the fundraising.
Cowdery, who is executive chair of the company, said: “Resolution Life will continue to grow and release trapped capital and stranded costs for life insurers across a number of markets. I am delighted to welcome our cornerstone investors onto our board.”
Source: Financial News
Can’t stop reading? Read more
Valuation differences halt EQT’s Oxford Biomedica takeover push
Valuation differences halt EQT’s Oxford Biomedica takeover push EQT has opted not to proceed with a takeover offer for Oxford Biomedica after the British cell and gene therapy manufacturer rejected four separate proposals, Reuters reported. Oxford Biomedica confirmed...
Novacap closes $3.8bn Tech Fund VII, surpassing target by over $1bn
Novacap closes $3.8bn Tech Fund VII, surpassing target by over $1bn Novacap has closed its Technologies Fund VII at nearly $3.8bn, exceeding its $2.75bn target by more than $1bn in under a year, the firm announced. The vehicle marks Novacap’s largest fund to date and...
L Catterton partner Todd Bartee takes helm at Tonal as private equity reshapes connected fitness
L Catterton partner Todd Bartee takes helm at Tonal as private equity reshapes connected fitness L Catterton has strengthened its operational oversight at portfolio company Tonal by appointing Operating Partner Todd Bartee as Chief Executive Officer. Bartee succeeds...